SIGNIFY
Study assessInG the morbidity–mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
- Stage
- klaar
- Medicine
- ivabradine
- Population
- ASCVD
- Phase
- III
- First Patient In
- 15 May 2009
- Last Patient In
- 1 May 2012
- Last Patient Last Visit
- -
Study Director
